Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119145) titled 'The application of Tegileridine Fumarate Injection in patients undergoing thoracoscopic lung resection surgery' on Feb. 24.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Affiliated Drum Tower Hospital, Medical School of Nanjing University
Condition:
Lung Cancer
Intervention:
Control group:Sufentanil 0.03 µg/kg/h Dexamethasone 15 mg Ondansetron 12 mg
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-07
Target Sample Size: Control group:86;Experimental group:86;
Countries of Recruitment:
China
To know more, visit https://www.chictr....